BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 25502895)

  • 21. Translating basic research in cancer patient care.
    Maugeri-Saccà M; De Maria R
    Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision medicine in pediatric oncology: Lessons learned and next steps.
    Mody RJ; Prensner JR; Everett J; Parsons DW; Chinnaiyan AM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27748023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the art discovery with tumor profiling in pediatric oncology.
    Carroll WL; Raetz E; Meyer J
    Am Soc Clin Oncol Educ Book; 2015; ():e601-7. PubMed ID: 25993229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translating genomics in cancer care.
    Bombard Y; Bach PB; Offit K
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic discoveries and treatment advances in neuroblastoma.
    Bagatell R; Cohn SL
    Curr Opin Pediatr; 2016 Feb; 28(1):19-25. PubMed ID: 26576010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Clinical Study of Precision Oncology in Solid Tumors.
    Sohal DP; Rini BI; Khorana AA; Dreicer R; Abraham J; Procop GW; Saunthararajah Y; Pennell NA; Stevenson JP; Pelley R; Estfan B; Shepard D; Funchain P; Elson P; Adelstein DJ; Bolwell BJ
    J Natl Cancer Inst; 2015 Nov; 108(3):. PubMed ID: 26553780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
    Marron JM; DuBois SG; Glade Bender J; Kim A; Crompton BD; Meyer SC; Janeway KA; Mack JW
    Pediatr Blood Cancer; 2016 Nov; 63(11):1974-82. PubMed ID: 27429135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapies of solid cancers: new options, new challenges.
    Awada A; Aftimos PG
    Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological network modelling and precision medicine in oncology].
    Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
    Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of tumor sequencing on the use of anticancer drugs.
    Thomas F; Desmedt C; Aftimos P; Awada A
    Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Landscape of early clinical trials for childhood and adolescence cancer in Spain.
    Bautista F; Gallego S; Cañete A; Mora J; Diaz de Heredia C; Cruz O; Fernández JM; Rives S; Madero L; Castel V; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L
    Clin Transl Oncol; 2016 Jul; 18(7):708-13. PubMed ID: 26489424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted therapy of soft tissue sarcomas.
    Wardelmann E; Chemnitz JM; Wendtner CM
    Onkologie; 2012; 35 Suppl 1():21-7. PubMed ID: 22286584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational medicine promising personalized therapy in oncology.
    Zeng YX; Zhang XS; Liu Q
    Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
    [No Abstract]   [Full Text] [Related]  

  • 40. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
    J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.